SCG Cell Therapy Pte. Ltd. is a clinical-stage biotechnology company headquartered in Singapore, with operations across Singapore, China and Germany, developing novel immunotherapies for infectious diseases and the cancers they cause. The company targets the most common cancer-causing infections — Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus (HBV) and Epstein-Barr virus (EBV) — and is advancing a pipeline of TCR-engineered T cell therapies, antibodies and therapeutic vaccines built on its proprietary GianTCR platform. Lead programs include SCG101, a first-in-class autologous HBV-specific TCR-T therapy targeting hepatitis B surface antigen in HBV-related hepatocellular carcinoma, and SCG142, a next-generation HPV E7-specific TCR-T therapy for HPV-associated solid tumors that received FDA IND clearance. SCG covers the full value chain from drug discovery and manufacturing through clinical development and commercialization. It is a therapeutics developer, not a software vendor, and publishes no public API, developer portal or machine-readable contract.
SCG Cell Therapy is profiled on the APIs.io network. Tagged areas include Biotechnology, Cell Therapy, Immunotherapy, Oncology, and Infectious Diseases.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: scg-cell-therapy
name: SCG Cell Therapy
description: SCG Cell Therapy Pte. Ltd. is a clinical-stage biotechnology company headquartered in Singapore, with operations
across Singapore, China and Germany, developing novel immunotherapies for infectious diseases and the cancers they cause.
The company targets the most common cancer-causing infections — Helicobacter pylori, human papillomavirus (HPV), hepatitis
B virus (HBV) and Epstein-Barr virus (EBV) — and is advancing a pipeline of TCR-engineered T cell therapies, antibodies
and therapeutic vaccines built on its proprietary GianTCR platform. Lead programs include SCG101, a first-in-class autologous
HBV-specific TCR-T therapy targeting hepatitis B surface antigen in HBV-related hepatocellular carcinoma, and SCG142, a
next-generation HPV E7-specific TCR-T therapy for HPV-associated solid tumors that received FDA IND clearance. SCG covers
the full value chain from drug discovery and manufacturing through clinical development and commercialization. It is a therapeutics
developer, not a software vendor, and publishes no public API, developer portal or machine-readable contract.
url: https://raw.githubusercontent.com/api-evangelist/scg-cell-therapy/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Biotechnology
- Cell Therapy
- Immunotherapy
- Oncology
- Infectious Diseases
- Clinical Trials
- Life Sciences
- Healthcare
- Pharmaceuticals
- Singapore
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/scg-cell-therapy-domain-security.yml
- type: Website
url: https://www.scgcell.com/
- type: LinkedIn
url: https://sg.linkedin.com/company/scgcell
- type: LLMsTxt
url: llms/scg-cell-therapy-llms.txt
x-enrichment:
date: '2026-08-26'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: SCG Cell Therapy is a clinical-stage TCR-T cell therapy developer whose only web property is an Alibaba Cloud site-builder
marketing site; there is no developer portal, no api./developer./docs. subdomain resolves in DNS, and no GitHub organization
exists under any spelling of the company name.
evidence:
- url: https://www.scgcell.com/
status: 200
- url: https://www.scgcell.com/openapi.json
status: 404
- url: https://www.scgcell.com/llms.txt
status: 404
- url: https://api.github.com/orgs/scgcell
status: 404
- url: https://www.scgcell.com/.well-known/security.txt
status: 429
checked: '2026-08-26'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.